enVVeno Medical (NVNO) Other Operating Expenses (2021 - 2026)
enVVeno Medical (NVNO) posted quarterly Other Operating Expenses of -$4000.0 for Q1 2026, down 112.5% quarter-over-quarter from $32000.0 in Q1 2021.
enVVeno Medical (NVNO) Other Operating Expenses (2021 - 2026) Analysis & Trends
enVVeno Medical's Other Operating Expenses history runs 2 years deep, the most recent figure standing at -$4000.0 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn |
| 10 | enVVeno Medical | 7.06 Mn | 7.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,000.00 |
| Mar 31, 2021 | 32,000.00 |